Filing Details
- Accession Number:
- 0001181431-12-030000
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-15 13:00:00
- Reporting Period:
- 2012-05-11
- Filing Date:
- 2012-05-15
- Accepted Time:
- 2012-05-15 17:13:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236934 | J Paula Swain | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | Evp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-11 | 5,000 | $6.27 | 23,061 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-11 | 2,083 | $5.97 | 25,144 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-11 | 34,750 | $8.19 | 59,894 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-11 | 11,119 | $8.99 | 71,013 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-11 | 88,881 | $8.99 | 159,894 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-05-11 | 5,556 | $7.09 | 165,450 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-11 | 147,389 | $23.22 | 18,061 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-05-11 | 5,000 | $0.00 | 5,000 | $6.27 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-05-11 | 2,083 | $0.00 | 2,083 | $5.97 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-05-11 | 34,750 | $0.00 | 34,750 | $8.19 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-05-11 | 11,119 | $0.00 | 11,119 | $8.99 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-05-11 | 88,881 | $0.00 | 88,881 | $8.99 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2012-05-11 | 5,556 | $0.00 | 5,556 | $7.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-08-14 | No | 4 | M | Direct | |
| 0 | 2012-11-06 | No | 4 | M | Direct | |
| 0 | 2014-02-12 | No | 4 | M | Direct | |
| 0 | 2015-01-17 | No | 4 | M | Direct | |
| 0 | 2015-01-17 | No | 4 | M | Direct | |
| 0 | 2014-02-11 | No | 4 | M | Direct |
Footnotes
- Beginning August 15, 2002 options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- Beginning November 7, 2002 options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- Beginning February 13, 2004 options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- Beginning January 18, 2005 options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- Beginning February 12, 2007 options become exercisable in 25 installments, with the first installment of 33.33% vesting after one year and the remaining vesting monthly over two years.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $23.10 to $23.50.
Billionaire Hedge Funds
